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The major venom component of Micrurus mipartitus, a coral snake distributed from
Nicaragua to northern South America, was characterized biochemically and functionally.
This protein, named mipartoxin-I, is a novel member of the three-ﬁnger toxin superfamily,
presenting the characteristic cysteine signature and amino acid sequence length of the
short-chain, type-I, a-neurotoxins. Nevertheless, it varies considerably from related toxins,
with a sequence identity not higher than 70% in a multiple alignment of 67 proteins within
this family. Its observed molecular mass (7030.0) matches the value predicted by its amino
acid sequence, indicating lack of post-translational modiﬁcations. Mipartoxin-I showed
a potent lethal effect in mice (intraperitoneal median lethal dose: 0.06 mg/g body weight),
and caused a clear neuromuscular blockade on both avian and mouse nerve-muscle
preparations, presenting a post-synaptic action through the cholinergic nicotinic receptor.
Since mipartoxin-I is the most abundant (28%) protein in M. mipartitus venom, it should
play a major role in its toxicity, and therefore represents an important target for developing
a therapeutic antivenom, which is very scarce or even unavailable in the regions where this
snake inhabits. The structural information here provided might help in the preparation of
a synthetic or recombinant immunogen to overcome the limited venom availability.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Snake venoms are recognized as a vast, yet largely
unexplored source of bioactive proteins with potent toxic
effects. Acquisition of such toxic proteins was accom-
plished through the recruitment of a small number of
’non-toxic’ genes for expression in specialized oral glands,
followed by an accelerated evolution process of divergence, Instituto Clodomiro
ax: þ505 2292 0485.
onte).
. All rights reserved.and neofunctionalization under strong positive selection
(Nakashima et al., 1993; Fry et al., 2006). This evolutionary
pathway allowed the advanced snakes (Caenophidia) to
undergo a striking change in their mode of subduing
prey, shifting from a mechanical (based on constriction)
to a biochemical (based on venom injection) strategy
(Calvete et al., 2009).
Highly venomous snakes of medical relevance are
classiﬁed within the families Atractaspidae, Viperidae, and
Elapidae (Fry et al., 2003a,b). The latter contains over 60
genera and nearly 300 species, one-third of which belong
to ‘coral snakes’, a major radiation encompassing six genera
P. Rey-Suárez et al. / Toxicon 60 (2012) 851–863852distributed in Asia and the Americas. The New World coral
snakes are currently classiﬁed within the genera Micrurus,
Micruroides, and Leptomicrurus, the former being the most
diverse, including over 70 species (Castoe et al., 2007).
Is spite of the extraordinary biological diversity and
complexity of coral snakes, distribued from Southern USA
to Argentina, factors such as low venom yields, and their
poor survival in captivity, pose important limitations for
the study of their venoms, as well as for the production
of therapeutic antivenoms. Nevertheless, newer sensitive
techniques for protein analysis have opened possibilities
to characterize such scarce biological materials, and
accordingly, a few proteomes of Micrurus venoms have
been described recently (Olamendi-Portugal et al., 2008;
Fernández et al., 2011; Corrêa-Netto et al., 2011; Rey-Suárez
et al., 2011; Ciscotto et al., 2011).
Micrurus mipartitus, commonly known as ‘redtail coral
snake’, ‘rabo de ají’, or ‘gargantilla’, inhabits the Caribbean
versants of Nicaragua, Costa Rica, the central Panamá
isthmus, and large areas of Ecuador, Colombia, and
Venezuela. Although this snake causes few human enve-
nomings in comparison to pitvipers (family Viperidae),
accidents may be fatal if unattended. Patients present
peripheral neurotoxic manifestations such as bilateral
ptosis and progressive respiratory paralysis which may
require ventilatory support (Otero, 1994). A major medical
difﬁculty in dealing with envenomings by M. mipartitus is
the scarcity, or even complete unavailability in most of its
geographic range, of a speciﬁc therapeutic antivenom. This
problem is aggravated by the lack of cross-protection by
more readily available antivenoms prepared against species
such as the Central American coral snake Micrurus nigro-
cinctus, due to their antigenic differences (Cohen et al.,
1971; Bolaños et al., 1975, 1978; Rey-Suárez et al., 2011).
Proteomic analyses of the venoms of M. mipartitus
from Colombia and Costa Rica were recently reported
(Rey-Suárez et al., 2011), aiming to provide a basic platform
that could be useful in the design of an antivenom.
The study identiﬁed a prominent venom component
belonging to the three-ﬁnger toxin (3FTx) family which
caused lethality in mice. In the present work, this protein
was isolated and characterized biochemically and func-
tionally as a potent short-chain neurotoxin. The protein,
named mipartoxin-I, is a new member of the 3FTx super-
family which shows considerable amino acid sequence
differences with other short-chain neurotoxins described
in the venoms of Elapidae snakes, including otherMicrurus
species. Due to its abundance in the venom ofM.mipartitus,
and its high toxicity, the primary structure and three-
dimensional modeling of mipartoxin-I here reported
might be useful for the preparation of an immunogen,
recombinant or synthetic, to elicit neutralizing antibodies
for the treatment of envenomings by this snake species.
2. Materials and methods
2.1. Venom and toxin isolation
Venom was collected from ﬁve adult specimens of
M. mipartitus from Antioquia, Colombia. The venom was
pooled, lyophilized, and stored at 20 C. Fractionation ofvenom (2 mg in 200 mL of water containing 0.1% triﬂuoro-
acetic acid; TFA) was performed by RP-HPLC on a C18
column (4.6  250 mm, 5 mm particle; Teknokroma) using
an Agilent 1200 chromatograph. Elution was performed
at 1 ml/min by applying a gradient toward acetonitrile
containing 0.1% TFA (solution B), as follows: 5% B for 5 min,
5–15% B over 10 min, 15–45% B over 60 min, and 45–70% B
over 12 min, as previously described (Rey-Suárez et al.,
2011). Absorbance was monitored at 215 nm, and the
major peak eluting atw26.5 min, named mipartoxin-I, was
manually collected, dried in a vacuum centrifuge (Savant),
and stored at 20 C.
2.2. MALDI-TOF mass spectrometry (MS)
Mipartoxin-I was diluted in water containing 0.1% TFA,
and dilutions ranging from 1000 to 10 ng weremixed at 1:1
with either saturated sinapinic acid or a-cyano-hydrox-
ycinnamic acid in 50% acetonitrile, 0.1% TFA, and spotted
(1 mL) onto an OptiToF-384 plate for MALDI-TOF MS anal-
ysis. Spectra were acquired on an Applied Biosystems
4800-Plus instrument, in linear positive mode, using 500
shots/spectrum and a laser intensity of 4200, over the m/z
range 4000–40,000. External calibration was performed
with CalMix-5 standards (ABSciex) spotted on the same
plate.
2.3. Electrospray ionization (ESI) MS
Mipartoxin-I, dissolved in 10 mL of 0.1% formic acid, was
loaded in a capillary tip (Proxeon) for direct infusion in
a nano-ESI source coupled to an Applied Biosystems Q-Trap
3200 mass spectrometer. Ionization was performed at
1200 V and spectra were acquired in positive Enhanced
Multi-Charge mode, in the m/z range 400–1600. Charge-
state and deconvolution of the ion series were analyzed
with the aid of the Bayesian protein reconstruction tool
of BioAnalyst v.1.5 software (ABSciex), and conﬁrmed by
manual calculation.
2.4. Amino acid sequencing
Mipartoxin-I (250 mg) was dissolved in 50 mM ammo-
nium bicarbonate and subjected to reduction with dithio-
threitol (10 mM) and alkylation with iodoacetamide
(50 mM). An aliquot of the reduced-alkylated protein was
subjected to N-terminal sequencing on a Shimadzu PPSQ-
33A Protein Sequencer, according to the manufacturer. The
rest of thismaterial was digested overnight with sequencing
grade bovine trypsin (in 25 mM ammonium bicarbonate,
10% acetonitrile) at 37 C. The resulting tryptic peptides
were separated by RP-HPLC on a C4 column (4.6 150 mm;
Vydac), eluted at 1 ml/min with a 0–70% acetonitrile
gradient over 40 min, and manually collected. Each peak
was subjected to MS/MS fragmentation and de novo amino
acid sequencing, using the above-mentioned mass spec-
trometers. For MALDI-TOF-TOF analyses, fragmentation
spectra were acquired at 2 kV in positive reﬂectron mode,
using a-cyano-hydroxycinnamic acid as matrix, 500 shots/
spectrum, and a laser intensity of 3000. Spectra were
searched using the Paragon algorithm of ProteinPilot 4.0
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or interpreted manually. Peptides that did not produce
well-resolved fragmentation spectra using MALDI were
further subjected to nESI-MS/MS. Selected doubly- or triply-
charged peptide ions were analyzed in Enhanced Resolution
mode (250 amu/s), and fragmented using the Enhanced
Product Ion tool, with Q0 trapping. Settings were: Q1, unit
resolution; collision energy, 25–45 eV; linear ion trap Q3 ﬁll
time, 250 ms; and Q3 scan rate, 1000 amu/s. The resulting
spectra were manually interpreted with the aid of the
BioAnalyst 1.5 Manual Sequencing tool.
2.5. Homology modeling
The Swiss-Model automated protein structure
homology-modeling server (http://swissmodel.expasy.org/;
Kiefer et al., 2009) was used tomodel the three-dimensional
structure of mipartoxin-I. Proteins with highest sequence
identity to this toxin were searched with this server and
tested as templates. The resulting models were super-
imposed and examined using Swiss-PDB Viewer v.4.0
(http://www.expasy.org/spdbv/; Guex and Peitsch, 1997) or
DS Viewer Pro v.6.0 (Accelrys). The best model was obtained
when using as template the crystal structure coordinates of
CTXA5, a non-cytolytic cardiotoxin variant from the venom
of the cobra Naja atra (PDB code 1KXI), having 38% amino
acid sequence identity. The resulting model of mipartoxin-I
was evaluated with ProCheck (Laskowski et al., 1993).
2.6. Phylogenetic relationships
Phylogenetic relationships of mipartoxin-I to other
members of the 3FTx superfamily were analyzed using 67
related amino acid sequences from venom proteins isolated
from the genera Micrurus, Pseudonaja, Ophiophagus, Oxy-
uranus, Bungarus, Naja, Dendroaspis, Haemachatus, and Aspi-
delaps, selected by a standard protein BLAST search (Altschul
et al.,1990). A hypothetical uncharacterized protein from theFig. 1. Isolation of mipartoxin-I from the crude venom of Micrurus mipartitus. Venom
particle size), using a water/acetonitrile gradient as described in Materials and Met
w16.5 min, and analyzed by SDS-PAGE (15% gel) under reducing conditions (insertlizard Anolis carolinensis (code XP_003217978) was utilized
as outgroup. Amino acid sequences were retrieved from
GenBank (access codes indicated in Fig. 5) and aligned
using BioEdit v.7.0 (Hall, 1999). The ﬁnal number of
amino acid positions was 79, after including gaps to maxi-
mize alignments, and the aligned sequences were ordered
by descending percent identity values in comparison to
mipartoxin-I. Phylogenetic inference was calculated by the
Bayesan inference algorithm,performedwithMrBayes v.3.1.2
(Ronquist and Huelsenbeck, 2003). A search for the amino
acid substitution model that better described the evolutive
process of themultiple sequence alignment of the 3FTxswas
performed with the ProtTest software (Abascal et al., 2005),
using the Akaike selection criterium.2.7. Animals
Male Swiss mice (25–30 g) were obtained from the
Multidisciplinary Center for Biological Investigation
(CEMIB/UNICAMP), and male HY-LINE W36 chicks (4–8
days old) were supplied by Granja Globo Aves Agrovícola
(Mogi Mirim, SP, Brazil). These animals were housed at
25  3 C on a 12 h light/dark cycle with free access to food
and water, and were used for the ex vivo neurotoxicity
studies at the University of Campinas. CD-1 mice (16–18 g)
of either sex were used for lethality assays at the University
of Costa Rica. All experiments were performed following
protocols approved by the corresponding institutional
committees for the ethical use of research animals.2.8. Mouse lethality assay
Variable doses of mipartoxin-I, dissolved in 250 mL of
0.04 M sodium phosphate, 0.12 MNaCl buffer (PBS; pH 7.2),
were injected by the intraperitoneal route in CD-1 mice
(16–18 g). Deaths were scored after 48 h, and the median
lethal dose (LD50) was calculated by probits (Trevors, 1986).(2 mg) was fractionated by RP-HPLC on a C18 column (4.6  250 mm, 5 mm
hods. The arrow indicates the peak corresponding to mipartoxin-I, eluting at
). Molecular weight markers (mw) are indicated at the left, in kDa.
Fig. 2. Molecular mass analyses of mipartoxin-I by (A) MALDI-TOF in posi-
tive linear mode, and (B) direct infusion nESI-MS in positive enhanced
multi-charge mode, as described in Materials and Methods. The inset (C)
shows the deconvolution of the multi-charged ion series shown in (B).
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Phrenic nerve-diaphragm preparations (Bülbring, 1946)
were obtained from mice anesthetized with isoﬂurane
(Cristália, Brazil) and euthanized by exsanguination. The
diaphragm was removed and mounted under a tension of
5 g in a 5 ml organ bath containing Tyrode solution (pH 7.4,
37 C) of the following composition (mM): NaCl 137, KCl 2.7,
CaCl2 1.8, MgCl2 0.49, NaH2PO4 0.42, NaHCO3 11.9, and
glucose 11.1, aerated with 95% O2 and 5% CO2. Supra-
maximal stimuli (4 threshold, 0.1 Hz, 0.2 ms for indirect
stimulation and 70 Hz, 0.2 ms for tetanic stimulation)Fig. 3. Primary structure determination of mipartoxin-I. The complete sequence w
combined with de novo sequencing of tryptic fragments of the toxin by MALDI-TOF-T
right shows the m/z values and charge state of tryptic fragments that were sequenc
the experimental values observed by both MALDI-TOF and nESI-MS analyses, showdelivered from a Grass S48 stimulator were applied to the
nerve through bipolar electrodes. Isometric muscle twitch-
tension was recorded by a force-displacement transducer
(Load Cell BG-10 GM) coupled to a Gould model RS3400
physiograph via a Gould universal ampliﬁer. The prepara-
tions were allowed to stabilize for at least 20min before the
addition of mipartoxin-I (0.1 or 0.5 mg/ml).
2.10. Chick biventer cervicis preparation
Biventer cervicis muscles obtained from male chicks
(Ginsborg and Warriner, 1960) sacriﬁced with isoﬂurane
were mounted under a tension of 1 g/0.5 cm in a 5 ml organ
bath containing warmed (37 C), aerated (95% O2, 5% CO2)
Krebs solution of the following composition (mM):
NaCl 118.7, KCl 4.7, CaCl2 1.8, NaHCO3 25, MgSO4 1.17,
KH2PO4 1.17, and glucose 11.65, pH 7.5. A bipolar platinum
ring electrode was placed around the tendon within which
runs the nerve trunk supplying themuscle. Field stimulation
(0.1 Hz, 0.2ms, 4–6 V) was donewith a Grass S48 stimulator
(Astro-Med Inc.).Muscle contractions and contractureswere
recorded isometrically via a force-displacement transducer
(Load Cell BG-10 GM, Kulite Semiconductor Products)
coupled to a Gould model RS3400 physiograph via a Gould
universal ampliﬁer (Gould Inc.). Contractures to exogenously
applied acetylcholine (ACh, 110 mM) and KCl (40 mM) were
obtained in the absence of ﬁeld stimulation prior to the
addition ofmipartoxin-I and at the end of the experiment, as
a test for the presence of myotoxic and neurotoxic activities
(Harvey et al., 1994). The preparations were allowed to
stabilize for at least 20min before the addition of ACh, KCl or
mipartoxin-I (0.1 or 0.5 mg/ml) to the bath. Twitch-tension
responses to mipartoxin-I were monitored for up to
60 min, depending on the toxin concentration. In some
preparations pretreated with mipartoxin-I (0.5 mg/ml),
neostigmine (6 mM) was added after 80% twitch-tension
blockade to examine whether the neurotransmission can
be recovered.
2.11. Membrane resting potential
The effect of mipartoxin-I on the membrane resting
potential and miniature end-plate potentials (MEPPs)
was recorded using mouse hemidiaphragm muscle
mounted in a lucite chamber containing Tyrode solution
(pH 7.0), as previously described (Oshima-Franco et al.,as obtained by N-terminal Edman degradation (amino acid residues 1–38)
OF or nESI-MS-MS, as described in Materials and Methods. The column at the
ed de novo. The amino acid sequence predicts a molecular mass that matches
n in Fig. 2.
Fig. 4. Homology modeling of the three-dimensional structure of mipartoxin-I. Cardiotoxin CTXA5, a 3FTx from the cobra Naja atra (PDB code 1KXI), having 38%
amino acid sequence identity (aligned at the bottom), was used as template in the Swiss-Model homology-modeling server, as described in Materials and
Methods. (A) Backbone superposition of Naja cardiotoxin CTXA5 (gray) and mipartoxin-I (red). The arrow points at the major structural difference, located in the
third loop of the “three-ﬁnger” structure. (B) Structural model of mipartoxin-I, in ribbons representation, showing the N- and C-terminus, and the characteristic
loops (1, 2, and 3) of the three-ﬁnger toxins. Disulﬁde bonds are represented as yellow sticks. (C) surface electrostatic potential representation of the structural
model shown in (B). Blue: positive; red: negative. Images were drawn with the DS Viewer software v.6.0. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
P. Rey-Suárez et al. / Toxicon 60 (2012) 851–863 8552004). In experiments conducted to record both, RP and
MEPPs (displayed on a Tektronix oscilloscope) measure-
ments were obtained at various intervals from control (t0)
and toxin-treated preparations (t15, t30, t45 and t60).
MEPPs amplitude was grouped in 0.4 mV intervals. Some
preparations were incubated with toxin for 60 min, and
exogenous carbachol (Cch, 12.5 mg/ml) was added to the
organ bath to test its ability to induce membrane
depolarization.
2.12. In vitro cytotoxicity
Mipartoxin-I was added to subconﬂuent cultures of
C2C12 myogenic cells (ATCC CRL-1772) to test for cytolytic
activity. After 3 h of incubation at 37 C, the lactate dehy-
drogenase activity of supernatants (40 mL) was determined
using a kinetic UV assay (LDH, Biocon). Culture medium
alone (Dulbecco’s modiﬁcation of Eagle’s mediumwith 10%
fetal calf serum), or medium containing 0.1% Triton X-100,
were used as reference points for 0 and 100% cytotoxicity,
respectively (Lomonte et al., 1999). The crude venom of the
cobra Naja nigricollis, which contains abundant 3FTxs
cytotoxins (Méndez et al., 2011), was used as a positive
control.
2.13. Statistical analyses
Each experimental protocol for neurotoxic assays was
repeated four times and the results were reported as
the mean  SEM. Repeated-measures analysis of variance
(ANOVA) was used for statistical comparison of the data,
with a value of p < 0.05 indicating signiﬁcance. All data
analyses were performed using the OriginPro v.8.0
software.3. Results
3.1. Isolation of mipartoxin-I
Using the RP-HPLC gradient previously developed
for the proteomic characterization of the venom of
M. mipartitus from Colombia (Rey-Suárez et al., 2011), the
prominent peak eluting atw26.5 min (Fig. 1), here named
mipartoxin-I, was puriﬁed. Integration of the signal peak
area at 215 nm indicates that this toxin represents 28% of
the total venom proteins. SDS-PAGE of mipartoxin-I under
reducing conditions showed a single band migrating at
w10 kDa (Fig. 1 insert), a slightly higher value than
expected on the basis of MS analyses (see below). A tryptic
peptide (m/z 463.2þ2) obtained after in-gel digestion of the
protein band initially identiﬁed it as a member of the 3FTx
superfamily, by presenting the de novo sequence L(I)K(Q)
CYVSR by nESI-MS-MS. This protein was isolated by
running the RP-HPLC procedure four times (2 mg of crude
venom per run), with reproducible results.
3.2. Mass spectrometry and amino acid sequence
Homogeneity and molecular mass of mipartoxin-I
were evaluated by MALDI-TOF (Fig. 2A) and nESI-MS
(Fig. 2B) analyses. The ﬁrst conﬁrmed the high purity of the
isolated protein, in particular showing no contamination
with components in the molecular mass range of phospho-
lipases A2 (w13,000d14,000; Fig. 2A), which are also
abundant components of this venom. By nESI-MS (Fig. 2B),
the molecular mass of mipartoxin-I was calculated at
7030.0 0.5 by deconvolution of its observedmulti-charged
state m/z values (Fig. 2C). The mass values observed by
MALDI-TOF and nESI-MS are in close agreement.
Fig. 5. Multiple sequence alignment of mipartoxin-I with three-ﬁnger toxins from elapid snake venoms. Protein access codes are indicated next to the snake
species name. The last column indicates the percent identity values (%Id) in comparison to mipartoxin-I. Cysteine residues are highlighted with a black
background.
P. Rey-Suárez et al. / Toxicon 60 (2012) 851–863856The complete amino acid sequence of mipartoxin-I was
determined, as shown in Fig. 3. The N-terminal 38 amino
acids were obtained by direct Edman sequencing of the
protein. De novo sequencing by MS/MS of HPLC-separatedtryptic fragments of the reduced and alkylated protein
provided four internal peptides (549.1þ1, 525.1þ2, 631.2þ1,
and 524.2þ1) that matched segments of the N-terminal
sequence, as well as two additional peptides that completed
P. Rey-Suárez et al. / Toxicon 60 (2012) 851–863 857the sequence (592.2þ2 and 844.3þ2). The predicted theo-
retical mass of the sixty-amino acid sequence is 7037.98
(average mass), which is in agreement with the observed
mass of 7030.0  0.5, considering the presence of eight
cysteines engaged in four disulﬁde bonds (loss of 8 Hþ),
characteristic of the short-chain 3FTx superfamily. Further,
the obtained sequence predicts mipartoxin-I to be a basic
protein, with a calculated pI of 8.5, according to the Compute
Mw/pI tool at http://web.expasy.org/compute_pI/. The
amino acid sequence of mipartoxin-I was submitted to the
SwissProt/UniProt database, and assigned the access code
B3EWF8.
3.3. Homology modeling
3FTxs for which three-dimensional structures are
available at the RCSB Protein Data Bank showed highest
sequence identity values with mipartoxin-I within the
range of 27–39%. After testing these different 3FTxs as
templates in the Swiss-Model server, the homology model
obtained using as template a non-cytolytic cardiotoxin
isoform from N. atra (1KXI; 38% amino acid sequence
identity), provided the best results, whereas the use of
other 3FTxs as templates provided poor models (data not
shown). Evaluation of the best model (vs. 1KXI) with Pro-
Check indicated 98% of residues in allowed regions (74.5%
in most favored regions, 19.6% in additional allowed
regions, and 3.9% in generously allowed regions). The pre-
dicted mipartoxin-I model superimposed over the back-
bone residues of the Naja 3FTx is shown in Fig. 4A. Their
structural comparison results in a r.m.s. value of 1.51 Å for
a-carbon atoms and 1.59 Å for backbone. The predicted
core region of mipartoxin-I is virtually identical to the
template, showing full spatial conservation of the disulﬁde
bonds. Slight spatial differences are predicted at the tips of
loops 1 and 2, whereas loop 3 presents a signiﬁcant devi-
ation (Fig. 4A) which is consistent with the presence of two
additional amino acids in the Naja toxin (formed by 62
residues).
3.4. Phylogenetic relationships
Sequence alignments of mipartoxin-I with 67 related
3FTx proteins fromnine elapid snake genera (Fig. 5) revealed
identity values ranging from 70% to 38% for proteins found in
other Micrurus venoms, with the exception of M. nigro-
cinctus, whose toxin presented only 23% sequence identity
compared tomipartoxin-I. Identity values dropped to 38% or
lower for proteins of elapid genera other than Micrurus,
when compared to mipartoxin-I. The number and positions
of cysteine residues of mipartoxin-I adhere to the conserved
scheme of the short-chain 3FTxs, presenting 8 cysteines
(Fig. 5).
A phylogeny of the elapid 3FTx sequences aligned in
Fig. 5 was reconstructed by Bayesian inference, using the
Akaike selection criterion and the WAG þ G amino acid
substitution model. The resulting phylogenetic tree pre-
sented a trichotomy, in which two groups are formed by
short-chain neurotoxins, while a third includes both short-
chain and long-chain neurotoxins, as well as short-chain
cytotoxins (Fig. 6). The ﬁrst group (“a” in Fig. 6) is wellsupported, with a posterior probability (PP) value of 0.95,
and subdivides into two lineages: one that includes only
short-chain cytotoxins, from Naja, Hemachatus, and Aspi-
delaps species, and another that includes the long-chain
neurotoxins from O. hannah, Naja melanoleuca and D. vir-
idis (PP ¼ 1.0) together with the short-chain neurotoxins
from Naja kaouthia, Naja sputatrix and B. candidus, which
form awell-supported group (PP¼ 1.0), and fromO. hannah,
D. angusticeps and M. nigrocinctus, whose phylogenetic
relationships within this branch cannot be conﬁdently
established. The second group (“b” in Fig. 6) is formed by all
the short-chain neurotoxins present in the different South
AmericanMicrurus species (M. mipartitus,Micrurus frontalis,
Micrurus altirostris, Micrurus corallinus and Micrurus sur-
inamensis), with the exception ofM. nigrocinctus, the Central
American coral snake. This second group is also well-
supported by signiﬁcant PP values, and although it is clear
that mipartoxin-I belongs to this group, its precise phylo-
genetic relationships with the other Micrurus toxins cannot
be conclusively established. The highest identity scores of
mipartoxin-I in the multiple alignment were obtained in
comparison to toxins from M. frontalis (P86421, 70%) and
M. altirostris (AED89567, 68%). Finally, the third group (“c” in
Fig. 6) is formed by short-chain neurotoxins from P. textilis,
O. scutellatus, O. microlepidotus, D. coronoides, O. hannah and
B. fasciatus, with well-supported phylogenetic relationships
(PP¼ 0.95–1.0), except for the B. fasciatus toxin. The fact that
the same snake species may contain in its venom different
3FTxs that belong to several phylogenetic and functional
groups within this protein family is well reﬂected in the tree
shown in Fig. 6.
3.5. Toxic activities
Mipartoxin-I showed a potent lethal effect in mice,
when injected by the intraperitoneal route, with a median
lethal dose (LD50) of 0.06 mg/g body weight. Injected
animals rapidly showed a general decrease in their activity
followed by slow breathing, and died within few hours
after injection. On the other hand, the toxin was not cyto-
toxic to the myogenic C2C12 cells in vitro, at concentrations
up to 180 mg/ml.
Incubation of chick biventer cervicis preparations with
mipartoxin-I (0.1 or 0.5 mg/ml) resulted in complete and
irreversible neuromuscular blockade after 46  2 and
212min, respectively (Fig. 7A and B). This concentration-
dependence was also evident in the times required
for 50% blockade, which decreased by increasing toxin
concentration (21  0.8 and 8.4  0.7 min, respectively).
The toxin completely blocked the contractures to exoge-
nous ACh without affecting the responses to KCl, indicating
an effect on post-synaptic nicotinic receptor function,
without altering muscle ﬁber integrity. The twitch inhibi-
tion was not reverted by addition of neostigmine (6 mM)
after 80% blockade induced by mipartoxin-I (0.5 mg/ml,
n ¼ 3), as well as after successive washings; also neostig-
mine did not prevent the complete blockade induced by the
toxin, which continued being progressive at same time
interval as in absence of neostigmine (data not shown).
In mouse phrenic nerve-diaphragm preparations,
mipartoxin-I (0.5 mg/ml) caused complete neuromuscular
Fig. 6. Phylogenetic relationships of mipartoxin-I with three-ﬁnger toxins from elapid snake venoms. The sequences aligned in Fig. 5 were used to infer
a phylogenetic tree, as described in Experimental. A hypothetical protein from the lizard Anolis carolinensis was utilized as outgroup (Out). The position of
mipartoxin-I is pointed by a black arrow, within the group of related toxins from Micrurus species (gray shade). The three major functional groups within this
family of proteins (short-chain cytotoxins, long-chain neurotoxins, and short-chain neurotoxins) are indicated by colored right braces and shading. Posterior
probability values are shown in the tree nodes, when signiﬁcant (0.95). The three major branches (see Results) are indicated by letters (a, b, c).
Fig. 7. Neuromuscular blockade produced by mipartoxin-I on isolated chick
biventer cervicis preparations. (A) Concentration-dependent blockade
curves caused by two different toxin doses, in comparison to control values
(Krebs solution). (B) Representative record showing the neuromuscular
blockade induced by mipartoxin-I (0.5 mg/ml) at 37 C, the inhibition of
contractures to exogenous ACh (110 mM,:), and the lack of effect on the KCl
(40 mM, -) response. In (A), points represent the mean  SEM (n ¼ 4).
Asterisks indicate a statistically signiﬁcant difference (p < 0.05) in
comparison to the Krebs solution control.
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of 0.1 mg/ml, induced 21% blockade after 120 min. The
complete twitch-tension blockade in this type of prepara-
tion was totally reversed (97  2%) at 58  6 min, after
several washes (Fig. 8B). In mouse preparations pretreated
with mipartoxin-I (0.5 mg/ml) and under tetanic stimula-
tion (70 Hz, 0.2 ms, w4 V) there was a progressive time-
dependent decrease in the amplitude of the response
similar to that seen with a known post-synaptic acting
toxin, a-bungarotoxin (a non-depolarizing toxin, 1.0 mg/ml,
n ¼ 4) used as a positive-control (Fig. 8C).
Incubation with mipartoxin-I (0.5 mg/ml) did not alter
the diaphragm resting membrane potential measurements
(Fig. 9) after 60 min observation (control: 81  1.2-mV vs.
toxin: 79  1-mV; n ¼ 4). Exposure of toxin-pretreated
preparation to carbachol (Cch, 12.5 mg/ml) did not inter-
fere in the membrane potential values (78  1 mV after
15 min, and 82  1-mV after washing). Furthermore,
mipartoxin-I (0.5 mg/ml) did not alter the frequency of
MEPPs (37 7 at t0 to 274 at t45 min; n¼ 3; p> 0.05), but
signiﬁcantly decreased the MEPPs amplitude values at 15,
30 and 45 min incubation compared to basal values
(1.20 0.02; 0.98 0.01; 0.97 0.02 and 0.89 0.01mV at
t0, t15, t30 and t45 min, respectively; p < 0.05) as shown in
the inset of Fig. 9.
4. Discussion
The major protein component of the venom of
M. mipartitus from Colombia, here named mipartoxin-I,was isolated and characterized biochemically and func-
tionally. Elucidation of its primary structure conﬁrmed it as
a new member of the 3FTx superfamily, presenting the
characteristic cysteine signature and amino acid sequence
lenght of the short-chain (or “type-I”) a-neurotoxins (Fry
et al., 2003a,b). In similarity to all proteins of this family,
mipartoxin-I is a basic protein, with a predicted pI of 8.5. Its
observed molecular mass (Mr 7030 Da) matches the mass
calculated from its amino acid sequence, indicating the lack
of post-translational modiﬁcations. The anomalous migra-
tion of mipartoxin-I in SDS-PAGE, which overestimated its
molecular weight at w10 kDa, might be related to its
high isoelectric point, and hence, strong intrinsic positive
charge.
Alignment of the sequence of mipartoxin-I with other
proteins of the 3FTx family revealed considerable differ-
ences, with identity values not higher than 70%, andmostly
within the range of 25–55%. The highest divergence from
the few related toxins currently known in other Micrurus
species was observed in comparison to the main a-neuro-
toxin isolated from M. nigrocinctus (Rosso et al., 1996),
surprisingly showing only 23% sequence identity. The
Bayesian phylogenetic reconstruction of a large set of
3FTxs conﬁrmed the divergence between this toxin from
M. nigrocinctus, positionedwithin a clade of toxins fromOld
World elapid snakes, and mipartoxin-I, which is clearly
related to toxins reported in South American Micrurus
species, forming a monophyletic group. This ﬁnding is in
agreement with a recently reported species phylogeny of
Micrurus, in which M. mipartitus and Micrurus dissoleucus
form a monophyletic group distant from M. nigrocinctus
(Renjifo et al., 2012). Moreover, this divergence now clearly
explains the long-known lack of immune cross-recognition
of antivenoms prepared against M. nigrocinctus venom,
when tested against M. mipartitus venom (Cohen et al.,
1971; Bolaños et al., 1975, 1978; Rey-Suárez et al., 2011).
The large sequence divergence here demonstrated between
mipartoxin-I and M. nigrocinctus a-neurotoxin should be
expected to produce major antigenic differences between
the epitopes of these two toxins. On the other hand, the
higher identity values observed between mipartoxin-I and
two related toxins from M. frontalis (70%) and M. altirostris
(68%), suggest the possibility that antivenoms prepared
against these two South American coral snake species
might effectively cross-recognize and neutralize M. mipar-
titus venom, a hypothesis that deserves to be addressed
experimentally, considering the scarcity of a speciﬁc anti-
venom against M. mipartitus.
The three-dimensional structure of toxins, and not only
their primary structure, is crucial to their immunological and
neutralizing properties (Ménez,1985; Pergolizzi et al., 2005).
Homology modeling of mipartoxin-I predicted a high
structural similarity with CTXA5, a non-cytolytic 3FTx car-
diotoxin isoform from the cobra N. atra (Wu et al., 2006),
which provided the best template. It is interesting that the
use of other 3FTx a-neurotoxins as templates did not
provide acceptable models, in contrast to CTXA5. In func-
tional similarity with CTXA5, mipartoxin-I lacked cytolytic
activity when tested on the murine myogenic cell line
C2C12, differing in this regard from many proteins of the
3FTx family classiﬁed as cardiotoxins/cytotoxins which have
Fig. 8. Neuromuscular blockade produced by mipartoxin-I on isolated mouse phrenic nerve-diaphragm preparations. (A) Concentration-dependent blockade
curves caused by two different toxin doses, in comparison to control values (Tyrode solution). (B) Representative record showing the complete neuromuscular
blockade and the reversible blocking effect by washing (W), at 37 C. (C) Representative record for 0.5 mg of toxin/ml showing the effect on the tetanic stimulation
(0–60 min) compared with 1.0 mg of a-bungarotoxin/ml, as a positive-control. Note that the response to the tetanic stimulation after incubation with mipartoxin-I
was similar to that recorded after exposure to a-bungarotoxin. In (A), points represent the mean  SEM (n ¼ 4). Asterisks indicate a statistically signiﬁcant
difference (p < 0.05) in comparison to the Tyrode solution control.
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et al., 2011). CTXA5 has been reported to bind to avb3
integrins without exerting cytolysis (Wu et al., 2006).
Examination of the structural model of mipartoxin-I showsa highly conserved core in comparison to CTXA5, but slight
spatial differences at the tips of the loops 2 and 3, and
a major change in loop 3. The loops interconnecting these
all-b-sheet proteins have been associated with their target
Fig. 9. Lack of depolarization of the mouse hemidiaphragm muscle membrane resting potential by mipartoxin-I after 60 min, and signiﬁcant change in the
response to exogenous carbachol (Cch, 12.5 mg/ml) after 60 min compared to control preparations (T0). Points represent mean  SEM (n ¼ 4). Inset: effect of
mipartoxin-I (0.5 mg/ml) on the amplitude of MEPPs at room temperature before and at different times after exposure to toxin. Asterisks indicate a statistically
signiﬁcant difference (p < 0.05) in comparison to control preparations.
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and Doley, 2010; Kini, 2011), and hence with their func-
tional properties in vivo.
Considering the biochemical, structural, and phyloge-
netic characteristics of mipartoxin-I, together with its
high lethal action in mice (LD50 0.06 mg/g), its possible
neurotoxic activity was investigated. Mipartoxin-I caused
a clear neuromuscular blockade on both avian and
mammalian preparations. The biventer cervicis preparation
was more sensitive than the phrenic nerve-diaphragm
preparation, probably related to differences in the innerva-
tion of these two preparations, with avian muscle having
both focally- and multiply-innervated ﬁbers that can
respond to electrical stimulation or exogenous nicotinic
agonists (Hodgson and Wickramaratna, 2002). The inability
of neostigmine and several washings to revert the toxin-
induced inhibition in BC preparations agrees with the ﬁnd-
ings recently reported in preparations incubated with crude
venom of M. mipartitus (Renjifo et al., 2012). However,
possible species differences in the afﬁnity of this toxin for
its receptors cannot be ruled out. Mipartoxin-I inhibited
contractures to exogenous ACh, indicating a predominantly
post-synaptic action through the blockade of cholinergic
nicotinic receptor, as also suggested for other studies using
Micrurus venoms (Goularte et al., 1995; Seraﬁm et al., 2002;
Abreu et al., 2008; Camargo et al., 2011; Renjifo et al., 2012).
The post-synaptic action of mipartoxin-I was also indicated
by the absence of fade in the response to tetanic indirect
stimulation at 70 Hz. This tetanic pattern was similar to
that produced by a-bungarotoxin, a non-depolarizing toxin
(Gallacci and Oliveira, 1994; Serra and Oliveira, 2006;
Camargo et al., 2011). These results were corroborated
using carbachol to produce progressive depolarization of the
restingmembrane potential, whereas the toxin had no effecton this parameter, indicating an activity on the post-synaptic
nicotinic receptors.Moreover, the inability ofmipartoxin-I to
alter the MEPPs frequency, in contrast with its efﬁciency
in decreasing MEPPs amplitude, suggests that, like other
typical a-neurotoxins, the toxin binds nicotinic receptors
without interfering with the presynaptic mechanism of
neurotransmitter release. Taken together, these results
indicate that mipartoxin-I causes neuromuscular blockade
by a post-synaptic action in neuromuscular preparations, i.e.
a-neurotoxicity, without directly damaging muscle ﬁbers.
The small amounts of toxin available precluded further
characterization of its receptor subtype speciﬁcity. A recent
study evaluated the neuromuscular activity of the crude
venom of M. mipartitus on the chick biventer cervicis prep-
aration, and demonstrated a post-synaptic action (Renjifo
et al., 2012), in full agreement with the present ﬁndings
using its puriﬁed major neurotoxin, mipartoxin-I, and also
supporting the conclusion that this protein plays a central
role in the neurotoxicity of M. mipartitus venom.
The extraordinary biodiversity within the genus Micru-
rus, with more than 70 species described (Castoe et al.,
2007), seems to be also reﬂected in the wide divergence
emerging from the study of their venom toxins. Only
a handful of 3FTxs have been fully sequenced and func-
tionally characterized from Micrurus venoms (Rosso et al.,
1996; de Oliveira et al., 2000; Dokmetjian et al., 2009;
Moreira et al., 2010). Mipartoxin-I, isolated from M. mipar-
titus venom, is a novel member of the 3FTx superfamily with
a potent post-synaptic a-neurotoxic effect on both avian
and mammalian neuromuscular preparations, and lethal
action in mice. Since mipartoxin-I is the most abundant
(28%) protein in the venom of this coral snake species, it
would be expected to play a major role in its toxicity.
Therefore, mipartoxin-I should be a relevant target for the
P. Rey-Suárez et al. / Toxicon 60 (2012) 851–863862development of a therapeutic antivenom. Together with
its functional characterization, the structural information
reported in the present work might be useful in the prepa-
ration of a synthetic or recombinant immunogen to over-
come the scarcity of venom for immunization.
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